Inquiry: The Journal of Health Care Organization, Provision, and Financing (Apr 2022)

Reinfection by SARS CoV2 in Valle Del Cauca, Colombia: A Descriptive Retrospective Study

  • Isabel Cristina Hurtado MD, MsC,
  • Juan Sebastián Hurtado MD,
  • Sandra Lizeth Valencia Statistics,
  • Elisa María Pinzón MsC,
  • Ana Roció Guzmán MD,
  • María Cristina Lesmes MD, MsC

DOI
https://doi.org/10.1177/00469580221096528
Journal volume & issue
Vol. 59

Abstract

Read online

Introduction: In coronavirus cases, reinfection has been associated with short-term immunity and genetic changes in viruses which allow them to escape from immune response, viral genotyping is required to make the precise diagnosis of reinfection, but the suspicion occurs in patients with more than 90 days between the tests and total improvement between them. We made a descriptive retrospective study with the cases of reinfection in Valle del Cauca, Colombia. Results: We found up to June 30, 3249 cases with suspected reinfection, 1.1% of all cases. During the first infection episode, 68% of the patients had symptoms, while at the moment of reinfection, the percentage was 73.4%. 55% of the analyzed cases had symptoms in both infection episodes, hospitalization of reinfection cases was 2% during the first episode and 2.2% in the second one. Conclusion: the reinfection percentage was low, as well as the hospitalization and ICU cases. These results allow to define that in terms of the provision of healthcare services, reinfection defined in this study, does not generate any differences in care required vs the first episode.